Programs
Program 1 [2020]
Psychedelics Research: During the year 2020 RiverPsykhe successfully helped guide the conversation in the emerging psychedelic movement in deference to Native American health and sovereignty, as well as ethics, inclusivity, and best practices. RiverPsykhe team successfully launched the first all-womens democratic funding collaborative, called Femtheogen with 24 participants supporting women led efforts in the psychedelic field. We also successfully led the fundraising of over $200k for a Harvard Hospice study at Dana Farber Institute. We contributed to two Oregon efforts that successfully decriminalized possession of drugs and legalized psilocybin mushroom therapy. RiverPsykhe directors sat on the boards of MAPS and the Heffter Research Institute. Indigenous Medicine Support:In support of Native medicine conservation, RiverPsykhe staff provided core capacity building with the Indigenous Peyote Conservation Initiative by supplying an executive director, initiated construction of on-site buildings, developed conservation infrastructure, and produce a short documentary on the work for fundraising. Additionally, staff networked our indigenous partners with a variety of media outlets and reporters including Michael Pollan who featured our work in his new book released in 2021. RiverPsykhe supported the Comanche tribes in acquisition of land for their conservation efforts. Our team also initiated and funded to completion a multi-layered bio-cultural assessment of Iboga in Gabon and Ayahuasca in South America, as well as funded the first double blind study on the clinical effects of Iboga on Opiate Use Disorder. Impact investment portfolio: We launched a new impact investment portfolio towards catalytic change in the death care industry, indigenous food sovereignty, and innovative/ethical psychedelic businesses. We also completed an indigenous led Tobacco business feasibility study. RiverPsykhe helped to launch the first regenerative organic and non-profit cannabis company called Brother Davids, along with Sun and Earth creating the first regenerative cannabis certification. Qualitative Research: The core qualitative research team was established to complete the religious professionals qualitative study. Grants In 2020 we made over $1.9mm in 501c3 charitable grants.GeographiesNot indicatedDatesJan 1, 2020 – Dec 31, 2020Source990No causes providedNo populations provided–$2.2MPsychedelics Research and Indigenous Support
PSYCHEDELICS RESEARCH:DURING THE YEAR, RIVERPSYKHE SUCCESSFULLY HELPED GUIDE THE CONVERSATION IN THE EMERGING PSYCHEDELIC MOVEMENT IN DEFERENCE TO NATIVE AMERICAN HEALTH AND SOVEREIGNTY, AS WELL AS ETHICS, INCLUSIVITY, AND BEST PRACTICES. IN ADDITION, RIVERPSYKHE ADVANCED WORK TO STUDY THE QUALITATIVE IMPACTS OF PSYCHEDELIC USE BY RELIGIOUS PROFESSIONALS.WE CONTINUE TO ENGAGE IN CAPACITY BUILDING AND SUPPORT OF THE INDIGENOUS MEDICINE CONSERVATION FUND, A 501C3 FOR THE BENEFIT OF FIVE DISTINCT INDIGENOUS BIO CULTURES AROUND THE WORLD.RIVERPSYKHE DIRECTORS SAT ON THE BOARDS OF MAPS, THE HEFFTER RESEARCH INSTITUTE, THE INDIGENOUS MEDICINE CONSERVATION FUND, B. MORE, AND RIVERSTYX FOUNDATION. RIVERPSYKHE DIRECTORS SAT ON THE ADVISORY BOARD OF THE NYU CENTER FOR PSYCHEDELIC MEDICINE.INDIGENOUS MEDICINE SUPPORT:IN SUPPORT OF NATIVE MEDICINE CONSERVATION, RIVERPSYKHE STAFF PROVIDED CORE CAPACITY BUILDING WITH THE INDIGENOUS PEYOTE CONSERVATION INITIATIVE BY SUPPLYING AN EXECUTIVE DIRECTOR, INITIATED CONSTRUCTION OF ON-SITE BUILDINGS AND, DEVELOPED CONSERVATION INFRASTRUCTURE.ADDITIONALLY, STAFF NETWORKED OUR INDIGENOUS PARTNERS WITH A VARIETY OF MEDIA OUTLETS AND REPORTERS INCLUDING NATIONAL AND INTERNATIONAL CONFERENCES. IMPACT INVESTMENT PORTFOLIO:WE MAINTAINED AN IMPACT INVESTMENT PORTFOLIO TOWARDS CATALYTIC CHANGE IN THE DEATH CARE INDUSTRY, INDIGENOUS FOOD SOVEREIGNTY, NUTRIENT CYCLING, AND INNOVATIVE/ETHICAL PSYCHEDELIC BUSINESSES. QUALITATIVE RESEARCH:THE CORE QUALITATIVE RESEARCH TEAM COMPLETED THE RELIGIOUS PROFESSIONALS QUALITATIVE STUDY.GRANTS:IN 2023 WE MADE $5,000 IN 501C3 CHARITABLE GRANTS AND AWARDS.GeographiesNot indicatedDatesJan 1, 2023 – Dec 31, 2023Source990No causes providedNo populations provided–$488.6K
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)